Title : The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand--a clinical audit.

Pub. Date : 2014 Oct 17

PMID : 25331307






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand--a clinical audit. Metformin NADH:ubiquinone oxidoreductase subunit B3 Homo sapiens
2 AIM: Metformin, the most common hypoglycaemic agent used in type 2 diabetes, is associated with reduced serum vitamin B12 concentrations. Metformin NADH:ubiquinone oxidoreductase subunit B3 Homo sapiens
3 This cross sectional observational study determines the prevalence of low vitamin B12 status in people with type 2 diabetes on metformin therapy in both primary and secondary care in New Zealand. Metformin NADH:ubiquinone oxidoreductase subunit B3 Homo sapiens
4 CONCLUSION: Low serum B12 concentration is a common occurrence in people with type 2 Diabetes treated with Metformin. Metformin NADH:ubiquinone oxidoreductase subunit B3 Homo sapiens